ArticleJPRAS open2026
Successful revision surgery after postsurgical pyoderma gangrenosum following reduction mammaplasty: A case report.
Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postsurgical pyoderma gangrenosum (PSPG) is a rare neutrophilic dermatosis that occurs following surgical procedures and frequently mimics postoperative infection. Misdiagnosis may lead to repeated surgical debridement and disease progression due to pathergy. Reports describing safe reoperation following PSPG remain limited, creating uncertainty regarding subsequent reconstructive procedures. Case: We report the case of an 18-year-old woman with well-controlled perinatal HIV who developed PSPG following bilateral reduction mammaplasty. On postoperative day (POD) 2 she developed refractory fevers and blisters near the vertical incision. By POD 6, ulceration developed on the left breast T-junction, prompting hospital admission. Dermatologic consultation and biopsy confirmed neutrophilic dermatosis consistent with pyoderma gangrenosum (PG). Multidisciplinary management involving dermatology, infectious disease, and plastic surgery led to initiation of systemic corticosteroids and immunomodulatory therapy, resulting in progressive clinical improvement and complete wound healing by eight months. After sustained disease remission and negative pathergy testing, the patient underwent staged reconstructive revision to address hypertrophic scarring and contour deformity. Revision mastopexy and autologous fat grafting were performed while the patient remained on biologic immunomodulatory therapy, with operative techniques modified to minimize cutaneous trauma. The patient healed without recurrence of PG. Conclusion: Postsurgical pyoderma gangrenosum presents a unique challenge for reconstructive surgeons because surgical trauma may trigger disease progression or recurrence through pathergy. This case demonstrates that revision surgery may be feasible after PG remission when disease control is sustained and perioperative management is coordinated with dermatology. Continued immunomodulatory therapy and surgical techniques that minimize cutaneous trauma may help mitigate recurrence risk and facilitate safe reconstructive revision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.